Ioannou, P.; Katsigiannis, A.; Papakitsou, I.; Kopidakis, I.; Makraki, E.; Milonas, D.; Filippatos, T.D.; Sourvinos, G.; Papadogiannaki, M.; Lydaki, E.;
et al. Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates. Viruses 2023, 15, 756.
https://doi.org/10.3390/v15030756
AMA Style
Ioannou P, Katsigiannis A, Papakitsou I, Kopidakis I, Makraki E, Milonas D, Filippatos TD, Sourvinos G, Papadogiannaki M, Lydaki E,
et al. Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates. Viruses. 2023; 15(3):756.
https://doi.org/10.3390/v15030756
Chicago/Turabian Style
Ioannou, Petros, Athanasios Katsigiannis, Ioanna Papakitsou, Ioannis Kopidakis, Eirini Makraki, Dimitris Milonas, Theodosios D. Filippatos, George Sourvinos, Marina Papadogiannaki, Evaggelia Lydaki,
and et al. 2023. "Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates" Viruses 15, no. 3: 756.
https://doi.org/10.3390/v15030756
APA Style
Ioannou, P., Katsigiannis, A., Papakitsou, I., Kopidakis, I., Makraki, E., Milonas, D., Filippatos, T. D., Sourvinos, G., Papadogiannaki, M., Lydaki, E., Chamilos, G., & Kofteridis, D. P.
(2023). Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates. Viruses, 15(3), 756.
https://doi.org/10.3390/v15030756
